Ambea’s acquisition of Aleris’ care operations has been approved by the competition authority in Denmark

The competition authority in Denmark has decided to approve Ambea’s acquisition of Aleris’ care operations (”Aleris Care”).

Ambea has previously received regulatory approval from the competition authorities in Sweden and Norway regarding the acquisition of Aleris Care.

This means that the transaction, which was originally announced 16 October 2018, is expected to close in January 2019.

For more information, contact:

Jacob Persson, Head of Investor Relations 
Telephone: +46 (0)708 64 07 52
E-mail: jacob.persson@ambea.se

Ambea press contact
Telephone: +46 (0)10 33 00 501
E-mail: press@ambea.se

This information is such information that Ambea AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 13:30 CET on 29 November 2018.

Ambea, is present in care services, and has approximately 15,000 employees. We offer services in disabled care, individual and family care, and elderly care with a focus on residential care and own management. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. Total revenue and adjusted EBITA for the 2017 financial year amounted to SEK 5,816 million and SEK 498 million. The company was founded in 1996 and its head office is located in Solna, Sweden. Ambea is listed on Nasdaq Stockholm.